Logo image of PRX.AS

PROSUS NV (PRX.AS) Stock Fundamental Analysis

Europe - Euronext Amsterdam - AMS:PRX - NL0013654783 - Common Stock

51.34 EUR
-0.78 (-1.5%)
Last: 12/8/2025, 7:00:00 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to PRX. PRX was compared to 14 industry peers in the Broadline Retail industry. PRX is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. PRX is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! With these ratings, PRX could be worth investigating further for growth investing!.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

PRX had positive earnings in the past year.
In the past year PRX had a positive cash flow from operations.
In the past 5 years PRX has always been profitable.
The reported operating cash flow has been mixed in the past 5 years: PRX reported negative operating cash flow in multiple years.
PRX.AS Yearly Net Income VS EBIT VS OCF VS FCFPRX.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B

1.2 Ratios

PRX's Return On Assets of 17.04% is amongst the best of the industry. PRX outperforms 92.86% of its industry peers.
PRX's Return On Equity of 24.23% is fine compared to the rest of the industry. PRX outperforms 78.57% of its industry peers.
The Return On Invested Capital of PRX (0.21%) is worse than 71.43% of its industry peers.
Industry RankSector Rank
ROA 17.04%
ROE 24.23%
ROIC 0.21%
ROA(3y)14.42%
ROA(5y)16.58%
ROE(3y)20.97%
ROE(5y)23.47%
ROIC(3y)N/A
ROIC(5y)N/A
PRX.AS Yearly ROA, ROE, ROICPRX.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

1.3 Margins

PRX has a Profit Margin of 200.44%. This is amongst the best in the industry. PRX outperforms 100.00% of its industry peers.
PRX's Profit Margin has improved in the last couple of years.
PRX has a worse Operating Margin (3.05%) than 71.43% of its industry peers.
PRX has a Gross Margin of 42.53%. This is comparable to the rest of the industry: PRX outperforms 42.86% of its industry peers.
In the last couple of years the Gross Margin of PRX has grown nicely.
Industry RankSector Rank
OM 3.05%
PM (TTM) 200.44%
GM 42.53%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-12.61%
PM growth 5Y12.1%
GM growth 3Y20.87%
GM growth 5Y4.2%
PRX.AS Yearly Profit, Operating, Gross MarginsPRX.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 200 300 400

7

2. Health

2.1 Basic Checks

PRX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for PRX has been reduced compared to 1 year ago.
The number of shares outstanding for PRX has been increased compared to 5 years ago.
The debt/assets ratio for PRX has been reduced compared to a year ago.
PRX.AS Yearly Shares OutstandingPRX.AS Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B
PRX.AS Yearly Total Debt VS Total AssetsPRX.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.2 Solvency

PRX has an Altman-Z score of 5.10. This indicates that PRX is financially healthy and has little risk of bankruptcy at the moment.
PRX has a better Altman-Z score (5.10) than 78.57% of its industry peers.
The Debt to FCF ratio of PRX is 9.30, which is on the high side as it means it would take PRX, 9.30 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 9.30, PRX is in line with its industry, outperforming 50.00% of the companies in the same industry.
A Debt/Equity ratio of 0.30 indicates that PRX is not too dependend on debt financing.
The Debt to Equity ratio of PRX (0.30) is better than 71.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 9.3
Altman-Z 5.1
ROIC/WACC0.03
WACC7.57%
PRX.AS Yearly LT Debt VS Equity VS FCFPRX.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10B 20B 30B 40B 50B

2.3 Liquidity

A Current Ratio of 3.54 indicates that PRX has no problem at all paying its short term obligations.
PRX's Current ratio of 3.54 is amongst the best of the industry. PRX outperforms 100.00% of its industry peers.
A Quick Ratio of 3.50 indicates that PRX has no problem at all paying its short term obligations.
PRX has a Quick ratio of 3.50. This is amongst the best in the industry. PRX outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 3.54
Quick Ratio 3.5
PRX.AS Yearly Current Assets VS Current LiabilitesPRX.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

7

3. Growth

3.1 Past

PRX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 103.26%, which is quite impressive.
The Earnings Per Share has been growing by 17.24% on average over the past years. This is quite good.
The Revenue has grown by 12.86% in the past year. This is quite good.
Measured over the past years, PRX shows a quite strong growth in Revenue. The Revenue has been growing by 13.13% on average per year.
EPS 1Y (TTM)103.26%
EPS 3Y-3.39%
EPS 5Y17.24%
EPS Q2Q%161.96%
Revenue 1Y (TTM)12.86%
Revenue growth 3Y-0.36%
Revenue growth 5Y13.13%
Sales Q2Q%10.17%

3.2 Future

PRX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.49% yearly.
PRX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.09% yearly.
EPS Next Y19.16%
EPS Next 2Y20.3%
EPS Next 3Y19.53%
EPS Next 5Y10.49%
Revenue Next Year27.87%
Revenue Next 2Y27.08%
Revenue Next 3Y22.22%
Revenue Next 5Y13.09%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
PRX.AS Yearly Revenue VS EstimatesPRX.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B 10B
PRX.AS Yearly EPS VS EstimatesPRX.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4 5

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 11.56, which indicates a very decent valuation of PRX.
Compared to the rest of the industry, the Price/Earnings ratio of PRX indicates a rather cheap valuation: PRX is cheaper than 100.00% of the companies listed in the same industry.
PRX is valuated cheaply when we compare the Price/Earnings ratio to 26.34, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 15.27 indicates a correct valuation of PRX.
85.71% of the companies in the same industry are more expensive than PRX, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of PRX to the average of the S&P500 Index (23.56), we can say PRX is valued slightly cheaper.
Industry RankSector Rank
PE 11.56
Fwd PE 15.27
PRX.AS Price Earnings VS Forward Price EarningsPRX.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PRX indicates a slightly more expensive valuation: PRX is more expensive than 71.43% of the companies listed in the same industry.
PRX's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 80.49
EV/EBITDA 388.78
PRX.AS Per share dataPRX.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

PRX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as PRX's earnings are expected to grow with 19.53% in the coming years.
PEG (NY)0.6
PEG (5Y)0.67
EPS Next 2Y20.3%
EPS Next 3Y19.53%

3

5. Dividend

5.1 Amount

PRX has a yearly dividend return of 0.38%, which is pretty low.
PRX's Dividend Yield is a higher than the industry average which is at 1.33.
With a Dividend Yield of 0.38, PRX pays less dividend than the S&P500 average, which is at 2.31.
Industry RankSector Rank
Dividend Yield 0.38%

5.2 History

The dividend of PRX decreases each year by -19.73%.
Dividend Growth(5Y)-19.73%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

2.17% of the earnings are spent on dividend by PRX. This is a low number and sustainable payout ratio.
DP2.17%
EPS Next 2Y20.3%
EPS Next 3Y19.53%
PRX.AS Yearly Income VS Free CF VS DividendPRX.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B
PRX.AS Dividend Payout.PRX.AS Dividend Payout, showing the Payout Ratio.PRX.AS Dividend Payout.PayoutRetained Earnings

PROSUS NV

AMS:PRX (12/8/2025, 7:00:00 PM)

51.34

-0.78 (-1.5%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)11-24 2025-11-24
Earnings (Next)N/A N/A
Inst Owners64.91%
Inst Owner ChangeN/A
Ins Owners0.88%
Ins Owner ChangeN/A
Market Cap122.14B
Revenue(TTM)6.17B
Net Income(TTM)12.37B
Analysts78.26
Price Target66.52 (29.57%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.38%
Yearly Dividend0.04
Dividend Growth(5Y)-19.73%
DP2.17%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.35%
PT rev (3m)15.18%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-3.85%
EPS NY rev (3m)-5.31%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)5.14%
Revenue NY rev (3m)3.05%
Valuation
Industry RankSector Rank
PE 11.56
Fwd PE 15.27
P/S 23.05
P/FCF 80.49
P/OCF 75.94
P/B 2.79
P/tB 2.87
EV/EBITDA 388.78
EPS(TTM)4.44
EY8.65%
EPS(NY)3.36
Fwd EY6.55%
FCF(TTM)0.64
FCFY1.24%
OCF(TTM)0.68
OCFY1.32%
SpS2.23
BVpS18.43
TBVpS17.87
PEG (NY)0.6
PEG (5Y)0.67
Graham Number42.9
Profitability
Industry RankSector Rank
ROA 17.04%
ROE 24.23%
ROCE 0.28%
ROIC 0.21%
ROICexc 0.3%
ROICexgc 0.31%
OM 3.05%
PM (TTM) 200.44%
GM 42.53%
FCFM 28.64%
ROA(3y)14.42%
ROA(5y)16.58%
ROE(3y)20.97%
ROE(5y)23.47%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-12.61%
PM growth 5Y12.1%
GM growth 3Y20.87%
GM growth 5Y4.2%
F-Score6
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 9.3
Debt/EBITDA 45.16
Cap/Depr 72.6%
Cap/Sales 1.72%
Interest Coverage 0.36
Cash Conversion 560.78%
Profit Quality 14.29%
Current Ratio 3.54
Quick Ratio 3.5
Altman-Z 5.1
F-Score6
WACC7.57%
ROIC/WACC0.03
Cap/Depr(3y)83.48%
Cap/Depr(5y)79.69%
Cap/Sales(3y)2.75%
Cap/Sales(5y)2.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)103.26%
EPS 3Y-3.39%
EPS 5Y17.24%
EPS Q2Q%161.96%
EPS Next Y19.16%
EPS Next 2Y20.3%
EPS Next 3Y19.53%
EPS Next 5Y10.49%
Revenue 1Y (TTM)12.86%
Revenue growth 3Y-0.36%
Revenue growth 5Y13.13%
Sales Q2Q%10.17%
Revenue Next Year27.87%
Revenue Next 2Y27.08%
Revenue Next 3Y22.22%
Revenue Next 5Y13.09%
EBIT growth 1Y212.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year343.24%
EBIT Next 3Y104.82%
EBIT Next 5YN/A
FCF growth 1Y181.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y169.5%
OCF growth 3YN/A
OCF growth 5YN/A

PROSUS NV / PRX.AS FAQ

Can you provide the ChartMill fundamental rating for PROSUS NV?

ChartMill assigns a fundamental rating of 6 / 10 to PRX.AS.


What is the valuation status for PRX stock?

ChartMill assigns a valuation rating of 6 / 10 to PROSUS NV (PRX.AS). This can be considered as Fairly Valued.


What is the profitability of PRX stock?

PROSUS NV (PRX.AS) has a profitability rating of 5 / 10.


Can you provide the financial health for PRX stock?

The financial health rating of PROSUS NV (PRX.AS) is 7 / 10.


Can you provide the expected EPS growth for PRX stock?

The Earnings per Share (EPS) of PROSUS NV (PRX.AS) is expected to grow by 19.16% in the next year.